About Genomicks
Genomicks was founded in 2016 and is headquartered in Petaling Jaya, Malaysia. Operations focus on the biotechnology sector, where medicines and diagnostic kits for fertility treatments are developed. Human embryo culture media products for in-vitro fertilisation (IVF) are being created, alongside HS Catheters used as balloon catheters to seal the uterus during injections, and IUI Catheters for intrauterine insemination procedures.
- Headquarter Petaling Jaya, Malaysia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Genomicks Sdn Bhd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genomicks
Detailed funding history for Genomicks
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Genomicks
Genomicks has secured backing from 1 investor. Prominent investors backing the company include BSV Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug research & development services for pharmaceutical sector
|
Locked | Locked | Locked |
Investor details for Genomicks
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genomicks
Investment portfolio details for Genomicks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genomicks
Detailed financials for Genomicks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genomicks Comparisons
Peer comparison for Genomicks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genomicks
Detailed competitors of Genomicks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genomicks
Complete news archive for Genomicks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomicks
Genomicks was founded in 2016.
Genomicks is headquartered in Petaling Jaya, Malaysia. It is registered at Petaling Jaya, Selangor, Malaysia.
Sanjiv Navangul is the current CEO of Genomicks.
Genomicks was founded in 2016 and is headquartered in Petaling Jaya, Malaysia. Operations focus on the biotechnology sector, where medicines and diagnostic kits for fertility treatments are developed. Human embryo culture media products for in-vitro fertilisation (IVF) are being created, alongside HS Catheters used as balloon catheters to seal the uterus during injections, and IUI Catheters for intrauterine insemination procedures.
Genomicks has 1 investor. Key investors include BSV Group.